Clinical trial
Efficacy and Safety of Broncho-Vaxom in Reducing Recurrence in Children With Steroid-sensitive Nephrotic Syndrome: Prospective, Randomized Controlled, Multicenter Clinical Study
NCT05044169 is registered in ClinicalTrials.gov with Fang Deng as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Broncho-Vaxom in Reducing Recurrence in Children With Steroid-sensitive Nephrotic Syndrome: Prospective, Randomized Controlled, Multicenter Clinical Study
- Lead sponsor
- Fang Deng
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2021
- Completion date
- December 31, 2023
- Enrollment
- 83 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
nephrotic syndrome in children